Target intelligence / Profile preview

Gastric H+/K+-exchanging ATPase (H+/K+-ATPase)

Target
H+/K+-ATPase
Molecular classification
Enzyme, Transporter, P-type ATPase, Hydrolase
01

Overview

The Gastric H+/K+-exchanging ATPase, commonly known as the gastric proton pump, is a P-type ATPase responsible for the final step of gastric acid secretion in the stomach. Located in the apical membrane of parietal cells, this heterodimeric enzyme (comprising alpha and beta subunits) exchanges cytoplasmic hydronium ions for extracellular potassium ions in an electroneutral process powered by ATP hydrolysis [1, 4]. This activity generates a massive proton gradient, maintaining the highly acidic environment (pH ~1.0) necessary for protein digestion and defense against ingested pathogens [6, 8]. Dysregulation or excessive activity of this pump contributes to acid-related disorders such as gastroesophageal reflux disease (GERD) and peptic ulcers [7, 10]. It is the primary therapeutic target for proton pump inhibitors (PPIs), which bind covalently and irreversibly to the enzyme, and newer potassium-competitive acid blockers (P-CABs), which inhibit the pump reversibly [2, 9]. Long-term pharmacological suppression of this target is associated with safety concerns including nutrient malabsorption and increased susceptibility to enteric infections [1, 7].

Other names
Gastric proton pumpProton pumpH+/K+ ATPaseGastric hydrogen potassium ATPaseATP4A/ATP4BAcid pump
02

Mechanism of action

Inhibition of gastric acid secretion through either irreversible covalent binding to cysteine residues (Proton Pump Inhibitors) or reversible competitive antagonism of the potassium-binding site (Potassium-Competitive Acid Blockers).

03

Biological functions

Gastric acid secretionIon transportpH regulationActivation of pepsinogenATP hydrolysis
04

Disease associations

Gastroesophageal reflux disease (GERD)Peptic ulcer diseaseGastritisZollinger-Ellison syndromeErosive esophagitisNSAID-induced gastropathy
05

Safety considerations

HypomagnesemiaVitamin B12 deficiencyIncreased risk of Clostridioides difficile infectionIncreased risk of bone fractures (osteoporosis)Rebound acid hypersecretionCommunity-acquired pneumonia risk
06

Interacting drugs

Omeprazole

9 more in the full profile.

07

Biomarkers

Gastric pHSerum gastrin levelsSerum chromogranin A

Beyond the preview

Go deeper on Gastric H+/K+-exchanging ATPase (H+/K+-ATPase).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Gastric H+/K+-exchanging ATPase (H+/K+-ATPase).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call